Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Duramed (DRMD) Synthetic Estrogen Product -- Ignore unavailable to you. Want to Upgrade?

To: Thure Meyer who wrote (652)	3/20/1998 1:23:00 PM
From: art slott	Respond to of 1837

Love that volume. There was a positive story on the health benefits of estrogen replacement therapy Thurs. Art

To: Thure Meyer who wrote (652)	3/20/1998 1:31:00 PM
From: Steven Messina,L.M.T.	Respond to of 1837

CNBC just did a nice bit on Duramed....stock is soaring. All the investment community had to hear was that Premarin was the most widely prescribed drug in the world, and that there was no generic equivalent due to FDA claims. In order to be considered "generic", the chemical structure (including all inert ingredients) must be EXACT. The generic Duramed wants to push does not contain the "exact" inert substances, from what has been reported. The FDA, for reasons we all know, considers the inert substances as "important". Inert ingredients?.....perhaps they should grab a dictionary and look up the word. Excellent daytrade...am all over it. Steve

To: Thure Meyer who wrote (652)	3/20/1998 1:31:00 PM
From: Robert L. Ray	Read Replies (1) \| Respond to of 1837

Has to be this Thure, At 1:18pm est Kate Bonner on CNBC gave a report on why Premarin had no gereric competition. Duramed and Barr Labs were mentioned. It was a really nice overview about the whole deal where Duramed's product wasn't approved last summer because of the missing questionable trace elements from the horse urine. She wound up by saying that Duramed was going to try and come out with it's very on version of Premarin instead of the strictly generic route and named the drug... Synestrin...spelling?.... And went on to say that Duramed was expected to file with the FDA about this drug before the end of the month... Sorry I didn't catch the exact name of what they were filing. And wound up the report by saying that it was possible that Duramed could have the drug approved by the end of the year. All in all it was a nice plug for Duramed. A group called Citizens against Government waste was also mentioned briefly. The report started before an advertisment with the teaser.... What drug which is one of the most widely prescsribed drugs in the world has no generic competition and why. Go Duramed:)